-
FDA Approves Focused Ultrasound for More Parkinson’s Symptoms
November 5, 2021
… symptoms, such as stiffness and slowness, as well as dyskinesia, which is involuntary, uncontrolled movement. ( MJFF funded early work on focused ultrasound for dyskinesia .) In FUS, doctors use MRI imaging to visualize … the globus pallidus interna for other PD motor symptoms and dyskinesia. During this procedure, a person is awake and …
-
Therapy for Movement Symptoms Shows Positive Results in Parkinson's Model
September 20, 2018
… to complications such as uncontrollable movements called dyskinesia. Foliglurax is designed to be taken in addition to levodopa to help alleviate symptoms such as dyskinesia. It targets the brain chemical glutamate, which … Register now for the October 18 webinar. Watch a video on dyskinesia. Maggie Kuhl Vice President Patient Engagement …
-
Vyalev (carbidopa/levodopa)
… with PD, this drug can contribute to involuntary movement (dyskinesia) or inconsistent symptom control (motor … motor symptoms, motor fluctuations and/or troublesome dyskinesia. Participants had at least 2.5 hours of “off” … infusion site (redness, swelling, etc), hallucinations and dyskinesia. The medical information contained in this …
-
Podcast: Limiting On-Off Periods in Parkinson's Medications
March 9, 2012
… may return. Those taking levodopa also risk developing dyskinesias, the excessive and uncontrollable movements that … levodopa could help to minimize both "off" periods and dyskinesias alike. In this podcast, Dave Iverson speaks with …
-
Philippe Huot, MD, PhD
… to alleviate parkinsonian disability, L-DOPA-induced dyskinesia and dopaminergic psychosis. The approaches used … the mechanisms and targets involved in parkinsonism, dyskinesia and psychosis, as well as the interaction of …
-
Combined Fenobam and Amantadine Treatment Promotes Robust Antidyskinetic Effects in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson's Disease
March 7, 2014
… to PD patients for counteracting levodopa-induced dyskinesia (LID) but therapeutic doses are not always … than what currently used might reduce levodopa-induced dyskinesia without diminishing the antiparkinsonian effect …